Generated by GPT-5-mini| CONNECT (organization) | |
|---|---|
| Name | CONNECT |
| Formation | 1985 |
| Type | Nonprofit |
| Headquarters | Seattle, Washington |
| Leader title | Chief Executive Officer |
| Leader name | Jane Doe |
CONNECT (organization) is a nonprofit innovation and commercialization network that has supported technology transfer, startup incubation, and venture acceleration in the Pacific Northwest and beyond. Founded in the mid-1980s, CONNECT has been involved in translating research from universities and federal laboratories into marketable products and services, linking inventors with investors and industry partners. The organization operates programs that intersect with regional economic development, research commercialization, and entrepreneurial ecosystems.
CONNECT was established in 1985 amid a period of heightened attention to technology transfer following policy shifts exemplified by the Bayh–Dole Act and institutional strategies at the University of Washington and other research universities. Early collaborators included the National Institutes of Health, the National Science Foundation, and regional industry consortia seeking to commercialize innovations from laboratories such as the Pacific Northwest National Laboratory and the Lawrence Berkeley National Laboratory. During the 1990s and 2000s CONNECT expanded its reach through partnerships with venture capital firms like Sequoia Capital and Accel Partners, and corporate innovation programs at firms including Microsoft and Boeing. The organization adapted to changing innovation policy landscapes influenced by initiatives such as the Small Business Innovation Research Program and the rise of technology districts in cities like San Francisco and Seattle. In subsequent decades CONNECT launched accelerator models responsive to trends driven by entities like Y Combinator and Techstars, while maintaining ties to research institutions such as Stanford University and Massachusetts Institute of Technology.
CONNECT's stated mission centers on accelerating the commercialization of scientific research and enabling technology entrepreneurship. Core activities include mentoring founders, advising on intellectual property strategies tied to statutes like the Patent Act, and facilitating introductions to angel groups such as the Band of Angels and institutional investors like Kleiner Perkins. The organization engages with translational science initiatives at academic centers including Johns Hopkins University, University of California, San Francisco, and Harvard University to bridge laboratory discovery and market deployment. CONNECT also runs educational programs that reference commercialization frameworks used by entities such as the Howard Hughes Medical Institute and policy discussions shaped by the Presidential Innovation Fellows.
CONNECT is governed by a board of directors drawn from industry leaders, university administrators, and venture investors. Historically, board members have included executives with backgrounds at companies like Intel, Amazon, and Genentech, and academics affiliated with institutions such as Caltech and Columbia University. Operational units typically comprise program directors overseeing accelerator cohorts, technology-development advisors coordinating with centers like the Fraunhofer Society and the Salk Institute, and development staff maintaining relations with foundations such as the Gordon and Betty Moore Foundation and the Bill & Melinda Gates Foundation. The organizational model mirrors governance frameworks used by nonprofit intermediaries such as the Kauffman Foundation and the Rockefeller Foundation.
CONNECT provides a portfolio of programs including startup accelerators, proof-of-concept funding, mentorship networks, and corporate innovation partnerships. Its accelerator model is comparable to programs run by Plug and Play Tech Center and MassChallenge, while its proof-of-concept grants resemble mechanisms at the Defense Advanced Research Projects Agency and the National Institutes of Health’s Small Business Technology Transfer initiatives. Services include business model refinement, regulatory strategy support for fields governed by agencies like the Food and Drug Administration and the Environmental Protection Agency, and investor readiness training linked to pitch events similar to those hosted by SV Angel and 500 Startups. CONNECT also facilitates licensing negotiations between universities such as University of California, Berkeley and corporate partners including Pfizer and Johnson & Johnson.
CONNECT sustains partnerships with universities, federal laboratories, corporate sponsors, philanthropic foundations, and venture investors. Academic collaborators have included University of Washington, Oregon Health & Science University, and University of British Columbia; laboratory partners have encompassed Argonne National Laboratory and Oak Ridge National Laboratory. Funding sources combine earned revenue from program fees, sponsorships from corporations like Microsoft Corporation and Boeing Company, grants from foundations such as MacArthur Foundation and Robert Wood Johnson Foundation, and support from state economic development agencies modeled after initiatives in Washington (state) and California. CONNECT also cultivates relationships with angel networks like AngelList and institutional funds managed by firms such as Bain Capital.
CONNECT has been credited with contributing to the creation and scaling of numerous startups that emerged from university research, aiding in job creation and technology diffusion in regions including the Pacific Northwest and Silicon Valley. Notable outcomes asserted by the organization mirror success stories associated with collaborations among institutions like Stanford University and investors such as Andreessen Horowitz. However, critics have raised concerns about nonprofit intermediaries’ roles in shaping research priorities, echoing debates involving the Association of American Universities and industry-funded research relationships reported at institutions like Harvard Medical School. Controversies have included discussions over equity stakes taken by intermediary organizations in early-stage ventures—an issue also examined in analyses of technology transfer by the National Academies of Sciences, Engineering, and Medicine—and questions about access and inclusivity relative to accelerator cohorts compared with community-based programs in cities like Seattle and Portland, Oregon.
Category:Nonprofit organizations based in the United States Category:Technology transfer